The trademark application Satoline was filed by Cellen Biotech Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on March 3, 2020, and it was registered by office on June 10, 2020 without any oppositions.
The application was filed in English (French was selected as the second language).